Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radia M Johnson

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
BMC Genomics|January 27, 2016
Cascade: an RNA-seq visualization tool for cancer genomicsAaron R Shifman, Radia M Johnson, Brian T Wilhelm
Genes & Development|June 4, 2014
MuLV-related endogenous retroviral elements and Flt3 participate in aberrant end-joining events that promote B-cell leukemogenesisRadia M Johnson, Eniko Papp, Ildiko Grandal, et al.
NPJ Breast Cancer|March 27, 2021
Co-dependency for MET and FGFR1 in basal triple-negative breast cancersVanessa Y C Sung, Jennifer F Knight, Radia M Johnson, et al.
Molecular Cell|June 30, 2019
Oncogenic Biogenesis of pri-miR-17∼92 Reveals Hierarchy and Competition among Polycistronic MicroRNAsAriel O Donayo, Radia M Johnson, Hsin-Wei Tseng, et al.
Cell Metabolism|October 10, 2017
PGC-1α Promotes Breast Cancer Metastasis and Confers Bioenergetic Flexibility against Metabolic DrugsSylvia Andrzejewski, Eva Klimcakova, Radia M Johnson, et al.
Nature Communications|July 1, 2018
Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional programAlison Hirukawa, Harvey W Smith, Dongmei Zuo, et al.
BMC Cancer|January 23, 2019
CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancerZi-Ming Zhao, Susan E Yost, Katherine E Hutchinson, et al.
Neuro-Oncology|September 8, 2020
Development of a gene expression-based prognostic signature for IDH wild-type glioblastomaRadia M Johnson, Heidi S Phillips, Carlos Bais, et al.
Cell Reports|August 9, 2016
The miR-17∼92 microRNA Cluster Is a Global Regulator of Tumor MetabolismSaid Izreig, Bozena Samborska, Radia M Johnson, et al.
Nature Communications|May 9, 2025
Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancerXueping Qu, Habib Hamidi, Radia M Johnson, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
BMC Genomics|January 27, 2016
Cascade: an RNA-seq visualization tool for cancer genomicsAaron R Shifman, Radia M Johnson, Brian T Wilhelm
Genes & Development|June 4, 2014
MuLV-related endogenous retroviral elements and Flt3 participate in aberrant end-joining events that promote B-cell leukemogenesisRadia M Johnson, Eniko Papp, Ildiko Grandal, et al.
NPJ Breast Cancer|March 27, 2021
Co-dependency for MET and FGFR1 in basal triple-negative breast cancersVanessa Y C Sung, Jennifer F Knight, Radia M Johnson, et al.
Molecular Cell|June 30, 2019
Oncogenic Biogenesis of pri-miR-17∼92 Reveals Hierarchy and Competition among Polycistronic MicroRNAsAriel O Donayo, Radia M Johnson, Hsin-Wei Tseng, et al.
Cell Metabolism|October 10, 2017
PGC-1α Promotes Breast Cancer Metastasis and Confers Bioenergetic Flexibility against Metabolic DrugsSylvia Andrzejewski, Eva Klimcakova, Radia M Johnson, et al.
Nature Communications|July 1, 2018
Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional programAlison Hirukawa, Harvey W Smith, Dongmei Zuo, et al.
BMC Cancer|January 23, 2019
CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancerZi-Ming Zhao, Susan E Yost, Katherine E Hutchinson, et al.
Neuro-Oncology|September 8, 2020
Development of a gene expression-based prognostic signature for IDH wild-type glioblastomaRadia M Johnson, Heidi S Phillips, Carlos Bais, et al.
Cell Reports|August 9, 2016
The miR-17∼92 microRNA Cluster Is a Global Regulator of Tumor MetabolismSaid Izreig, Bozena Samborska, Radia M Johnson, et al.
Nature Communications|May 9, 2025
Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancerXueping Qu, Habib Hamidi, Radia M Johnson, et al.
Pageof 3